Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
Molecular Imaging Research, Inc. - Medical Equipment - Deals and Alliances Profile
Publication Date Jun 2012
Publisher GlobalData
Product Type Report
Pages 14
Single User License help $ 250.00
Site User License help $ 500.00
Corporate User License help $ 750.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

Molecular Imaging Research, Inc. - Medical Equipment - Deals and Alliances Profile

Summary

Molecular Imaging Research, Inc. (Molecular Imaging) is a contract research organization, based in the US. The company provides preclinical assessments and evaluation of novel anti-cancer and anti-inflammatory therapeutic agents. The company employs wide array of novel imaging technologies including CT (µCT), preclinical MRI, high resolution PET (µPET), bioluminescence and fluorescence imaging for measuring the response derived at functional, anatomical and molecular levels. The additional services offered by the company include non-invasive imaging, in vitro testing, pharmacodynamics, preclinical efficacy testing, pharmacokinetics and consulting. It also conducts research and development for technologies to measure signal transduction, angiogenesis, apoptosis (proteases) and DNA damage. Molecular Imaging is headquartered in Ann Arbor, Michigan, the US.

Molecular Imaging Research, Inc. - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Molecular Imaging Research, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 4
Molecular Imaging Research, Inc., Medical Equipment Deals By Type, 2006 to YTD 2012 5
Molecular Imaging Research, Inc., Medical Equipment, Deals By Region, 2006 to YTD 2012 6
Molecular Imaging Research, Inc., Medical Equipment, Deals By Market, 2006 to YTD 2012 7
Molecular Imaging Research, Inc., Medical Equipment, Deals Summary, 2006 to YTD 2012 8
Molecular Imaging Research, Inc., Medical Equipment, Deal Details 9
Venture Financing 9
Molecular Imaging Research Raises Additional $2.85 Million In Series A Financing 9
Acquisition 11
Charles River Labs International Acquires Molecular Imaging Research 11
Molecular Imaging Research, Inc. - Key Competitors 12
Key Employees 12
Locations And Subsidiaries 13
Head Office 13
Appendix 14
Methodology 14
About GlobalData 14
Contact Us 14
Disclaimer 14

List of Tables
List of Tables
Molecular Imaging Research, Inc., Medical Equipment, Key Facts 1
Molecular Imaging Research, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 1
Molecular Imaging Research, Inc., Medical Equipment, Deals By Region, 2006 to YTD 2012 1
Molecular Imaging Research, Inc., Medical Equipment, Deals By Market, 2006 to YTD 2012 1
Molecular Imaging Research, Inc., Medical Equipment, Deals Summary, 2006 to YTD 2012 1
Molecular Imaging Research, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 4
Molecular Imaging Research, Inc., Medical Equipment Deals By Type, 2006 to YTD 2012 5
Molecular Imaging Research, Inc., Medical Equipment, Deals By Region, 2006 to YTD 2012 6
Molecular Imaging Research, Inc., Deals By Market, 2006 to YTD 2012 7
Molecular Imaging Research, Inc., Medical Equipment, Deals Summary, 2006 to YTD 2012 8
Molecular Imaging Research Raises Additional $2.85 Million In Series A Financing 9
Charles River Labs International Acquires Molecular Imaging Research 11
Molecular Imaging Research, Inc., Key Competitors 12
Molecular Imaging Research, Inc., Key Employees 12

List of Figures
List of Figures
Molecular Imaging Research, Inc., Medical Equipment, Deals by Type, 2006 to YTD 2012 1
Molecular Imaging Research, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 4
Molecular Imaging Research, Inc., Medical Equipment, Deals by Type, 2006 to YTD 2012 5
Molecular Imaging Research, Inc., Medical Equipment, Deals By Region, 2006 to YTD 2012 6
Molecular Imaging Research, Inc., Medical Equipment, Deals by Market, 2006 to YTD 2012 7

Title Date Price
2013 Deep Research Report on China Human Use Rabies Vaccine Industry
By QYResearch
2013 Deep Research Report on China Human Use Rabie Vaccine Industry is a professional and depth research report on China Human Use Rabies Vaccine industry. This report has firstly introduced Human Use ...Read More
Jan 2013 $2000.00
By Netscribes (India) Pvt. Ltd.
May 2012 $0.00
Abdominal Obesity-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Abdominal Obesity-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establ ...Read More
$1250.00
Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Abortion- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...Read More
$2000.00
Abortion-API Insights, 2014
By Delveinsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numb ...Read More
$1250.00
Abscess- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Abscess- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed ...Read More
$2000.00
Abscess-API Insights, 2014
By Delveinsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numb ...Read More
$1250.00
Abscess-Pipeline Insights, 2014
By Delveinsight
SUMMARYDelveInsight’s,“ Abscess-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the un ...Read More
$1250.00
Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
By Delveinsight
DelveInsight’s, “ Absence Seizure- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and m ...Read More
$2000.00
Absence Seizure-API Insights, 2014
By Delveinsight
SummaryThe active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large numb ...Read More
$1250.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   
   
For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z